Filed before 2025Filed 13 March 2023
Volastra Therapeutics, Inc. raised $60.2M
Volastra Therapeutics, Inc., a biotech company based in New York, NY, raised $60.2M in a new equity round, according to a filing dated 13 March 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 13 March 2023
- Round
- Equity round
- Amount sold
- $60.2M
- Offering size
- $60.2M
- Investors so far
- 13
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 95% of the 1,396 tracked raises with an amount filed in 2023, and than 85% of the 142 in biotech.
Volastra Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 23 Sep 2025 | New filing | $30.1M | Not tracked |
| 30 May 2024 | New filing | $15M | Another raise |
| 13 Mar 2023 | New filing | $60.2M | This raise |
More with Vida Ventures on the board
- MeridianMade, Inc.$20.3M
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Quanta Therapeutics, Inc.$76.2M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.